Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis

• Main Authors: Cui Li (Author), Jingmin Zhu (Author), Linghan Shan (Author), Yingyu Zhou (Author), Gang Liu (Author), Hong Zhu (Author), Qunhong Wu (Author), Yu Cui (Author), Zheng Kang (Author)
• Format: Book
• Published: BMC, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background The high costs of innovative anticancer drugs hinder a number of cancer patients' access to these drugs in China. To address this problem, in 2018, the medical insurance access negotiation (MIAN) policy was implemented, when the prices of 17 innovative anticancer drugs were...